Skip to main content

Table 2 Comparison of the PDS group with different IDS groups

From: Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study

 

n

Median PFS (95%CI) (months)

Median OS (95%CI) (months)

PDS group

90

12.1 (8.2–16.1)

35.8 (28.6–43.0)

IDS group

163

8.6 (6.9–10.3)

42.4 (29.6–55.2)

IDS-1 group

63

14.6 (7.7–21.5)

62.5 (44.5–80.4)

IDS-2 group

85

12.7 (7.4–18.0)

59.2 (30.1–88.3)

IDS-3 group

35

17.6 (0.0–36.1)a

NR ab

  1. a When compared with the PDS group, the difference was statistically significant (P < 0.05)
  2. b Not reached